VNS Algorithm for Advanced Dosing | NCT07725601

NCT07725601

Overview

NCT ID: NCT07725601
Lead Sponsor: Fernando ValeOTHER
Official Title: VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations "The Augusta Way"
Brief Summary: The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:

Does the modified programming of the VNS reduce seizures faster than the standard programming?

Participants in both groups will:

Attend up to 3 study visits every 3 months for 2 years

Answer questionnaires to assess quality of life and cognitive function

Maintain a diary of seizure activity
Conditions: Epilepsies
Interventions

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Subjects who are clinically determined to be candidates for VNS implantation for seizure control

Subject/legally authorized representative able to provide informed consent.

Exclusion Criteria:

Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention

Central Contacts: Brandy Quarles, MPHContact
bquarles@augusta.edu706-721-0390